Received Mar 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (DAPTACEL) | SANOFI PASTEUR | 4 | 4CA18C 1 | IM / RA |
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | 1 | U8889A A | IM / LA |
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 9N9P Y | IM / LA |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 9X25 4 | IM / RA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 4 | Y1D03P 1 | SC / LA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y00411 7 | SC / RA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 1 | Z01486 9 | SC / LA |
Vaccine administration error: Patient received Measles, Mumps, and Rubella (MMR) Vaccine MMR Lot# Y00411 7 that had expired on 02/12/2026. The error was discovered on 03/03/2026, after administration. Parent/guardian will be notified. No adverse reactions observed at the time of administration. Revaccination recommended =28 days after the expired dose was given.